Review Articles

Glaucoma: a brief update for 2017

Natalie Schellack, Gustav Schellack, Selente Bezuidenhout, Lucille Malan, Hanneke de Klerk
South African Family Practice | Vol 59, No 6 : November/December| a4661 | DOI: https://doi.org/10.4102/safp.v59i6.4661 | ©
Submitted: 07 March 2017 | Published:

About the author(s)

Natalie Schellack, Sefako Makgatho Health Sciences University, South Africa
Gustav Schellack,, South Africa
Selente Bezuidenhout, Sefako Makgatho Health Sciences University, South Africa
Lucille Malan, Sefako Makgatho Health Sciences University, South Africa
Hanneke de Klerk, Sefako Makgatho Health Sciences University, South Africa

Full Text:

PDF (234KB)

Share this article

Bookmark and Share

Abstract

Glaucoma is a complex condition of the eye and the second leading cause of blindness around the globe. It is an ophthalmic neurodegenerative condition and is characterised by a raised intra-ocular pressure (IOP). The latter also constitutes the only modifiable risk factor in glaucoma management. When left untreated patients may gradually experience a visual field loss, and even lose their sight completely. This article provides a brief overview of this condition, the pharmacological treatment options that are available in South Africa, as well as the rational use thereof.

Keywords

glaucoma; intra-ocular pressure; IOP; ocular hypertension; visual field loss; carbonic anhydrase

Metrics

Total abstract views: 845
Total article views: 315


Crossref Citations

No related citations found.